To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
Young European self-directed investor currently establishing a growth and income focused portfolio.
Long: ACN, BLK, CELG, DIS, GILD, GSK, KO, LVS, PCP, PEP, RPG, UL, V.
Dividend stock ideas & income, Retirement savings, Stocks - long
Currently, there is no company profile for whatoncewas.
Currently, there are no blog details for whatoncewas.
Currently, there are no book details for whatoncewas.
From Benzinga.com: Gilead Sciences, Inc. Reports Q2 EPS of $2.36 vs $1.79 Est; Revenue of $6.53B vs $5.86B Est $
Jul 23, 2014
Not sure where you sourced ...
Glaxo Q2 sales up 6%; net income off 84%; cash ...
2014Q2: EPS of $1.40. Reven...
McDonald's beats by $0.02, beats on revenue
Probably just less trading ...
ECB pledges to boost bond buying; euro drops
Agreed, doctorx. GAAP figur...
Johnson & Johnson beats by $0.02, beats on ...
Good article, good company....
A Look At Accenture's Explosive Dividend Growth
Paying A Dividend Is Efficient Capital Allocation
Xignite quote data
© 2015 Seeking Alpha